Some epidemiological aspects in patients suffering from myocardial infarction
Keywords:
MYOCARDIAL INFARCTION/complications/epidemiology.Abstract
A descriptive, retrospective, cross-sectional study was conducted to describe clinical-epidemiological aspects of patients suffering from myocardial infarction at Municipal Intensive Care Area in Sandino municipality, July 2008-2011. The target group was comprised of 45 patients that were previously diagnosed and the sample included 30 patients. Age, gender, addictive habits, the presence of hypertension, diabetes mellitus, along with familial records of coronary artery disease, origin, complications and thrombolytic therapy were the variables collected from the clinical charts. Ages from 60 to 69 were the most affected (46,7% of the total). The 90% of patients were older than 45 years old, most of them from urban zones 70,0% (Z=2,39; p=8,41E-0,3). The totality of patients had addictive habits and some of the risk factors explored (X2= 40,841; p<0, 01). The 76,66% smoked and 90% were hypertensive; 53,3% of the sample underwent streptokinase treatment. As complications for myocardial infarction 43,35% suffered from coronary artery disease (*Z=3,06; p=1,1E-04), both angina and arrhythmias were detected in 10 % of patients. Patients from 60 to 69 and from urban zones prevailed. A high proportion of patients with addictive habits (mainly tobacco smoking) was observed. Most of patients were hypertensive and presented some of the explored risk factors. The numbers of thrombolysis were higher than those described in the medical literature, but could be greater in the municipality. Heart failure was the most frequent complication. Few complications were reported, which stands out the function of the Municipal Intensive Care Areas.Downloads
References
1. Pearte CA, Furberg CD, O'Meara ES y colaboradores. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Circulation [on line] 2006[cited january 2011]; 113(18):2177-85. Available from: http://circ.ahajournals.org/content/113/18/2177.full.pdf+html
2. Plan Andaluz de urgencias y emergencias. Manejo del infarto agudo de miocardio. España: Sn; 2006. p. 21-29.
3. Wilson AM, Ryan MC, Boyle AJ. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol. 2006; 106(3): 291-7.
4. Lourbakos A, Yuan YP, Jenkins AL, Travis J, Andrade-Gordon P, Santulli R, et al. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood. 2006; 97(12):3790-7.
5. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J. 2006; 151(5): 977-84.
6. Piñón J, Sandrino M, Garcia R, Delgado A, Fernandez JL, Leon OA. Mortalidad oculta por infarto agudo del miocardio. Rev Cub Med [revista en internet] 2003[citado sept. 2011]; 42(5):1-6. Disponible en: http://bvs.sld.cu/revistas/med/vol42_5_03espe/med06503.htm
7. Cuba, Ministerio de Salud Pública, Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud. La Habana: MINSAP;2010. p.35.
8. Cabadés A, Echanove I, Cebrian J, Cardona J, Valls F, Parra V, et al. Características, manejo y pronóstico del paciente con infarto agudo de miocardio en la Comunidad Valenciana en 1995: resultados del registro PRIMVAC (Proyecto de Registro de Infarto Agudo de Miocardio de Valencia, Alicante y Castellón). Rev Esp Cardiol [revista en internet] 1999[citado sept. 2011]; 52: 123-133. Disponible en: http://www.revespcardiol.org/es/revistas/revista-española-cardiologia-25/caracteristicas-manejo-pronostico-paciente-infarto-agudo -miocardio-50-epidemiologia-factores-riesgo-prevencion-1999
9. Task Force Report. The pre-hospital management of acute heart attacks. Recommendations of a Task Force of the The European Society of Cardiology and The European Resuscitation Council. European Heart Journal [on line]. 1998 [cited sept. 2011]; 19, 1140-1164. Available from: http://www.escardio.org/guidelines-surveys/esc-guidelines/Scientific_Statements/Documents/guidelines-Prehosp-AH-Attacks-FT-1998.pdf
10. Bodoya A, Diez DI, Loaiza JA, Valencia JM, Vergel MA, Castaño O. Estudio descriptivo sobre infarto agudo del miocardio en el hospital de Caldas entre 1996-2002. Col Med[en internet] 2004[citado agosto 2011]; 35(3): 127-131. Disponible en: http://simef.univalle.edu.co/colombiamed/Vol35No3/cm35n3a1.htm
11. Leal Mateos M, Solano Chinchilla T. Tabaquismo como factor de riesgo del infarto agudo al miocardio. Acta méd. costarric 2006; 48(2):72-76. Disponible en: http://redalyc.uaemex.mx/pdf/434/43448204.pdf
12. Pérez Caballero D, Cordiés Jackson L, Vázquez Vigoa A, Serrano Verdura C. Hipertensión arterial. Programa Nacional de Prevención, Diagnóstico, Evaluación y Control de la Hipertensión Arterial. Guía para la atención médica. La Habana: MINSAP; 2004.p.256-287
13. Bermejo J, Segovia J, Heras M, Alfonso F. Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Chicago, Estados Unidos, 12 al 15 de noviembre 2006). Rev Med Cardiol[en internet] 2007[sept. 2011]; 60(2): 157-167. Disponible en: http://www.revespcardiol.org/es/revistas/revista-española-cardiologia-25/resumen-los-ensayos-clinicos-presentados-las-sesiones-13099462-articulo-especial-2007
14. Jericó C, Knobel H, Sorli ML, Montero M, Guelar A, Pedro-Botet J. Prevalencia de factores de riesgo cardiovascular en pacientes con infección por el VIH. Rev Clin Esp[en internet] 2006[citado sept. 2011]; 206(11): 556-9. Disponible en: http://www.elsevier.es/sites/default/files/elsevier/pdf/65/65v206n11a13096303pdf001.pdf
15. Rodríguez AD, González PA, González MJG, Hita JF. Asociación entre concentraciones séricas de interleucina 10 y desarrollo de insuficiencia cardiaca en pacientes con infarto agudo de miocardio tratados con angioplastia primaria. Rev Esp Cardiol[en internet] 2005[citado agosto 2011]; 58: 626-30. Disponible en: http://www.revespcardiol.org/es/linksolver/ft/id/13076717
16. Silva Ramos L. Guías de prácticas clínicas en áreas de terapia intensiva municipal. Bahía Honda 2006; 23-31.
17. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med[on line]. 2008[cited january 2011]; 358(13):1336-45. Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa072100
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/